diabetes cat

Diabetes equipment 640x426

Type 2 diabetes: the role of the practice pharmacist

2019-02-22T13:58:00+00:00By Muhammad Siddiqur Rahman

Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes


Co-morbidities in type 2 diabetes


Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed

Dr Kevin Fernando

Type 2 diabetes: what are the benefits and risks of glucose-lowering agents?


Dr Kevin Fernando explains how SIGN 154 offers evidence-based guidance on glucose control therapies for people with type 2 diabetes

Diabetes finger prick (cropped) 250x165

Top tips: type 2 diabetes


Dr Kevin Fernando provides top tips on diagnosing and managing type 2 diabetes and identifying people at high risk

nagi dinesh

An innovative diabetes service redesign in Wakefield

2017-01-12T00:00:00+00:00By Dr Dinesh Nagi

Dr Dinesh Nagi provides insight into an integrated model of care provided by primary care and specialist diabetes teams

More articles on diabetes

Test and reflect

Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.

More from Guidelines Learning

Educational resources

Final version_ADA-EASD checklist

Implementing the ADA and EASD 2018 consensus report: management of hyperglycaemia in type 2 diabetes

2019-05-27T08:24:00+01:00Commissioned by Boehringer Ingelheim Limited and Lilly Diabetes Alliance

Information intended for healthcare professionals only. This checklist has been commissioned and funded by Boehringer Ingelheim Limited and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice. Please see the bottom of the page for full disclaimer.

Final version_Jardiance FDG update

Jardiance® (empagliflozin) film-coated tablets

2019-05-23T12:20:00+01:00Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice.

Management of hyperglycaemia in T2D (animation)

Management of hyperglycaemia in type 2 diabetes, 2018: ADA/EASD consensus report

2019-04-09T09:38:00+01:00Commissioned by Napp Pharmaceuticals Limited

Watch this short animation, commissioned by Napp Pharmaceuticals Limited, to find out about the third joint consensus report on the management of hyperglycaemia in type 2 diabetes by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Related Guidelines summaries

  • Type 2 diabetes treatment pathway comparison

    Tue, 19 Mar 2019 08:57 GMT

    This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.

  • Type 2 diabetes: frailty in older people

    Fri, 15 Mar 2019 16:43 GMT

    Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.

  • NICE pancreatitis guideline

    Tue, 05 Feb 2019 12:19 GMT

    Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment.

  • Pancreatic exocrine insufficiency guideline

    Mon, 14 May 2018 08:00 GMT

    What are the signs of pancreatic exocrine insufficiency in diabetes? This concise management algorithm covers symptoms, investigations, and referral.

  • SIGN type 2 diabetes guideline

    Tue, 16 Jan 2018 11:53 GMT

    This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm